NEUE

NYSE:NEUE

NeueHealth

  • Stock

USD

Last Close

5.25

08/11 20:59

Market Cap

41.95M

Beta: 0.85

Volume Today

6.20K

Avg: 23.42K

PE Ratio

−0.04

PFCF: −0.02

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '21
Dec '22
Dec '23
net income
-1.18B
-
-1.36B
14.77%
-1.27B
6.92%
depreciation and amortization
35.48M
-
50.58M
42.53%
24.17M
52.22%
deferred income tax
-25.65M
-
2.03M
107.90%
-3.06M
251.11%
stock based compensation
68.42M
-
109.71M
60.35%
83.69M
23.72%
change in working capital
1.25B
-
1.16B
7.10%
-2.16B
285.98%
accounts receivables
-32.94M
-
28.79M
187.39%
-7.76M
126.94%
inventory
1.07B
-
1.17B
9.05%
-1.99B
269.87%
accounts payables
192.61M
-
2.70M
98.60%
-149.32M
5,638.76%
other working capital
14.90M
-
-42.76M
386.94%
-10.61M
75.18%
other non cash items
-59.98M
-
272.04M
553.57%
591.80M
117.54%
net cash provided by operating activities
82.06M
-
234.47M
185.73%
-2.73B
1,262.87%
investments in property plant and equipment
-30.41M
-
-27.45M
9.75%
-2.90M
89.45%
acquisitions net
-431.79M
-
-310K
99.93%
-682K
120%
purchases of investments
-1.02B
-
-1.46B
43.23%
-837.07M
42.57%
sales maturities of investments
926.90M
-
1.06B
13.87%
1.96B
85.72%
other investing activites
net cash used for investing activites
-552.89M
-
-429.72M
22.28%
1.12B
360.55%
debt repayment
-200M
-
-155M
22.50%
-66.40M
57.16%
common stock issued
898.72M
-
1.31M
99.85%
common stock repurchased
dividends paid
other financing activites
-10.08M
-
-4.31M
57.22%
-16.49M
282.60%
net cash used provided by financing activities
1.04B
-
1.07B
2.18%
49.91M
95.32%
effect of forex changes on cash
net change in cash
572.81M
-
871.11M
52.08%
-1.56B
278.74%
cash at beginning of period
488.37M
-
1.06B
117.29%
1.93B
82.09%
cash at end of period
1.06B
-
1.93B
82.09%
375.28M
80.58%
operating cash flow
82.06M
-
234.47M
185.73%
-2.73B
1,262.87%
capital expenditure
-30.41M
-
-27.45M
9.75%
-2.90M
89.45%
free cash flow
51.65M
-
207.02M
300.85%
-2.73B
1,418.46%

All numbers in USD (except ratios and percentages)